1. Home
  2. REAX vs WVE Comparison

REAX vs WVE Comparison

Compare REAX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • WVE
  • Stock Information
  • Founded
  • REAX 2018
  • WVE 2012
  • Country
  • REAX United States
  • WVE Singapore
  • Employees
  • REAX N/A
  • WVE N/A
  • Industry
  • REAX
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • WVE Health Care
  • Exchange
  • REAX Nasdaq
  • WVE Nasdaq
  • Market Cap
  • REAX 800.1M
  • WVE 915.6M
  • IPO Year
  • REAX N/A
  • WVE 2015
  • Fundamental
  • Price
  • REAX $4.49
  • WVE $9.76
  • Analyst Decision
  • REAX Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • REAX 3
  • WVE 16
  • Target Price
  • REAX $6.33
  • WVE $20.00
  • AVG Volume (30 Days)
  • REAX 1.2M
  • WVE 1.6M
  • Earning Date
  • REAX 08-07-2025
  • WVE 07-30-2025
  • Dividend Yield
  • REAX N/A
  • WVE N/A
  • EPS Growth
  • REAX N/A
  • WVE N/A
  • EPS
  • REAX N/A
  • WVE N/A
  • Revenue
  • REAX $1,617,846,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • REAX $44.55
  • WVE N/A
  • Revenue Next Year
  • REAX $16.68
  • WVE $4.55
  • P/E Ratio
  • REAX N/A
  • WVE N/A
  • Revenue Growth
  • REAX 72.57
  • WVE N/A
  • 52 Week Low
  • REAX $3.80
  • WVE $5.04
  • 52 Week High
  • REAX $6.75
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • REAX 62.72
  • WVE 72.03
  • Support Level
  • REAX $3.87
  • WVE $8.40
  • Resistance Level
  • REAX $4.58
  • WVE $9.03
  • Average True Range (ATR)
  • REAX 0.21
  • WVE 0.55
  • MACD
  • REAX 0.06
  • WVE 0.06
  • Stochastic Oscillator
  • REAX 87.41
  • WVE 98.53

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: